Iradimed (IRMD) EPS (Basic) (2013 - 2026)

Iradimed (IRMD) has reported EPS (Basic) for 14 consecutive years, with $0.41 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EPS (Basic) fell 10.11% year-over-year to $0.41 in Q2 2026; TTM through Jun 2026 was $1.8, a 14.52% increase from a year earlier, with the FY2025 full-year figure at $1.76, up 20.38% from the prior year.
• EPS (Basic) was $0.41 for Q2 2026 at Iradimed, down from $0.46 in the prior quarter.
• Over five years, EPS (Basic) peaked at $0.5 in Q4 2025 and troughed at $0.2 in Q1 2022.
• A 5-year average of $0.35 and a median of $0.36 in 2025 frame the typical range for EPS (Basic).
• Across the five-year window, EPS (Basic) jumped 116.18% in 2022 and dropped 15.4% in 2023, its largest moves.
• Over 5 years, EPS (Basic) stood at $0.29 in 2022, then dropped by 15.4% to $0.25 in 2023, then jumped by 41.93% to $0.35 in 2024, then soared by 42.54% to $0.5 in 2025, then retreated by 18.44% to $0.41 in 2026.
• The last three EPS (Basic) figures came in at $0.41 (Q2 2026), $0.46 (Q1 2026), and $0.5 (Q4 2025), per Business Quant data.